Cargando…

Role of the calmodulin inhibitor trifluoperazine on the induction and expression of cell cycle traverse perturbations and cytotoxicity of daunorubicin and doxorubicin (adriamycin) in doxorubicin-resistant P388 mouse leukaemia cells.

Detalles Bibliográficos
Autores principales:	Ganapathi, R., Yen, A., Grabowski, D., Schmidt, H., Turinic, R., Valenzuela, R.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001449/ https://www.ncbi.nlm.nih.gov/pubmed/3707847

Ejemplares similares

Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
por: Kamath, N., et al.
Publicado: (1993)

Modulation in vitro and in vivo of cytotoxicity but not cellular levels of doxorubicin by the calmodulin inhibitor trifluoperazine is dependent on the level of resistance.
por: Ganapathi, R., et al.
Publicado: (1988)

Restoration of doxorubicin responsiveness in doxorubicin-resistant P388 murine leukaemia cells.
por: Ramu, A., et al.
Publicado: (1984)

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.
por: Colombo, T., et al.
Publicado: (1996)

Trifluoperazine, a calmodulin antagonist, inhibits muscle cell fusion
Publicado: (1983)

Increased plasma membrane traffic in daunorubicin resistant P388 leukaemic cells. Effect of daunorubicin and verapamil.
por: Sehested, M., et al.
Publicado: (1987)

Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
por: Babudri, N., et al.
Publicado: (1984)

5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.
por: Ramu, A., et al.
Publicado: (1984)

Synthesis and Cytotoxic Evaluation of Arimetamycin A and Its Daunorubicin and Doxorubicin Hybrids
por: Huseman, Eric D., et al.
Publicado: (2021)

Doxorubicin-loaded PEG-PCL copolymer micelles enhance cytotoxicity and intracellular accumulation of doxorubicin in adriamycin-resistant tumor cells
por: Diao, Yuan-Yuan, et al.
Publicado: (2011)

Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
por: Kaaijk, P., et al.
Publicado: (1996)

Trifluoperazine prevents FOXO1 nuclear excretion and reverses doxorubicin-resistance in the SHG44/DOX drug-resistant glioma cell line
por: Chen, Xiaozhong, et al.
Publicado: (2018)

Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
por: Mircheva, J., et al.
Publicado: (1986)

Doxorubicin-transferrin conjugate selectively overcomes multidrug resistance in leukaemia cells
por: Łubgan, Dorota, et al.
Publicado: (2008)

Modulation of doxorubicin resistance in a doxorubicin-resistant human leukaemia cell by an immunoliposome targeting transferring receptor.
por: Suzuki, S., et al.
Publicado: (1997)

Intrinsic and extrinsic apoptosis responses in leukaemia cells following daunorubicin treatment
por: Al-Aamri, Hussain Mubarak, et al.
Publicado: (2021)

Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines
por: Mahbub, AA, et al.
Publicado: (2015)

Hydrophilic Polyhedral Oligomeric Silsesquioxane, POSS(OH)(32), as a Complexing Nanocarrier for Doxorubicin and Daunorubicin
por: Piorecka, Kinga, et al.
Publicado: (2020)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.
por: Smith, B. J., et al.
Publicado: (1976)

Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
por: Smith, P. J., et al.
Publicado: (1986)

A METHOD FOR COMPARING EFFECTS OF DIFFERENT SYNCHRONIZING PROTOCOLS ON MAMMALIAN CELL CYCLE TRAVERSE : The Traverse Perturbation Index
por: Tobey, Robert A., et al.
Publicado: (1972)

Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines
por: Mahbub, A A, et al.
Publicado: (2015)

Trifluoperazine-Induced Angioedema
por: Osman, Mugtaba, et al.
Publicado: (2014)

N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
por: Ganapathi, R., et al.
Publicado: (1989)

Determination of the DNA repair pathways utilised by acute lymphoblastic leukaemia cells following daunorubicin treatment
por: Al-Aamri, Hussain Mubarak, et al.
Publicado: (2019)

Time dependent response of daunorubicin on cytotoxicity, cell cycle and DNA repair in acute lymphoblastic leukaemia
por: Al-Aamri, Hussain Mubarak, et al.
Publicado: (2019)

P388 leukaemia cells resistant to the anthracycline menogaril lack multidrug resistant phenotype.
por: Badiner, G. J., et al.
Publicado: (1990)

Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
por: Pereira-Oliveira, Maria, et al.
Publicado: (2019)

Acquired resistance to daunorubicin in a patient with acute myelogenous leukaemia.
por: Smith, B. J., et al.
Publicado: (1976)

Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
por: Blair, Hannah A.
Publicado: (2018)

Pseudo-tetanus following trifluoperazine.
por: Shorten, G. D., et al.
Publicado: (1990)

Trifluoperazine-Induced Cholestatic Jaundice
por: Sharifi, Vandad, et al.
Publicado: (2010)

Hypokalemia with Trifluoperazine at Therapeutic Dose
por: Rehman, Sajjadur, et al.
Publicado: (2017)

Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel
por: Stanislaus, Anthony, et al.
Publicado: (2012)

Perturbation of microRNAs in Rat Heart during Chronic Doxorubicin Treatment
por: Vacchi-Suzzi, Caterina, et al.
Publicado: (2012)

Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.
por: Galettis, P., et al.
Publicado: (1994)

Correction to: Daunorubicin/Cytarabine Liposome: A Review in Acute Myeloid Leukaemia
por: Blair, Hannah A.
Publicado: (2018)

L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
por: Warrington, R. C., et al.
Publicado: (1989)

Drug targeting to decrease cardiotoxicity – determination of the cytotoxic effect of GnRH-based conjugates containing doxorubicin, daunorubicin and methotrexate on human cardiomyocytes and endothelial cells
por: Polgár, Livia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kmim3r746umg5seh50nolluk3p